ArticleTherapeutic advances in neurological disorders2026

OnabotulinumtoxinA for chronic migraine: A real-life multicenter study of 479 patients.

Marta Waliszewska-Prosół et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.